Spots Global Cancer Trial Database for recurrent colon cancer
Every month we try and update this database with for recurrent colon cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00492999 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00016198 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT00134069 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | sorafenib tosyl... cetuximab irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Antineoplaston Therapy in Treating Patients With Colon Cancer | NCT00003486 | Stage IV Colon ... Recurrent Colon... Adenocarcinoma ... | antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation... | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00049101 | Colorectal Canc... | erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | NCT00062426 | Colorectal Canc... | bevacizumab capecitabine fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine in Treating Patients With Advanced Colorectal Cancer | NCT00007943 | Colorectal Canc... | gemcitabine hyd... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer | NCT00027729 | Colorectal Canc... | etaracizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00004870 | Colorectal Canc... | oblimersen sodi... irinotecan hydr... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | NCT00504153 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... | dasatinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | NCT00571740 | Colorectal Canc... | bevacizumab cetuximab fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | NCT00005076 | Colorectal Canc... | cetuximab irinotecan hydr... | 18 Years - | University of Alabama at Birmingham | |
| Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | NCT01105377 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... | entinostat azacitidine laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| NGR-TNF in Treating Patients With Advanced Solid Tumors | NCT00098943 | Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu... | CNGRC peptide-T... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | NCT01846520 | Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung... | educational int... telephone-based... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | NCT00002828 | Colorectal Canc... | fluorouracil raltitrexed | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer | NCT00006103 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... | - | Alliance for Clinical Trials in Oncology | |
| SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00028015 | Colorectal Canc... | SarCNU | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00049101 | Colorectal Canc... | erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer | NCT00027729 | Colorectal Canc... | etaracizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | NCT00008060 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan in Treating Patients With Colorectal Cancer | NCT00003843 | Colorectal Canc... | irinotecan hydr... mutation analys... polymorphism an... | 18 Years - | California Cancer Consortium | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | NCT00835679 | Liver Metastase... Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | cetuximab dasatinib therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | NCT00138177 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... Unspecified Adu... | oxaliplatin leucovorin calc... vorinostat fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer | NCT00024401 | Colorectal Canc... | DHA-paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | NCT00003254 | Colorectal Canc... | ethynyluracil fluorouracil | 18 Years - | SWOG Cancer Research Network | |
| Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00003446 | Colorectal Canc... | fluorouracil leucovorin calc... trimetrexate gl... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer | NCT01320683 | Liver Metastase... Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | oxaliplatin leucovorin calc... fluorouracil bevacizumab yttrium Y 90 DO... laboratory biom... pharmacological... irinotecan hydr... | 18 Years - | City of Hope Medical Center | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | NCT01217450 | Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Unspecified Adu... | selumetinib cetuximab laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT00134069 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | sorafenib tosyl... cetuximab irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer | NCT00899210 | Colorectal Canc... Metastatic Canc... | laboratory biom... cryosurgery radiofrequency ... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00022477 | Colorectal Canc... | BMS-247550 | 18 Years - | University of Chicago | |
| Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | NCT00006269 | Colorectal Canc... Diarrhea | irinotecan hydr... octreotide acet... | 18 Years - | Novartis | |
| MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer | NCT02041481 | Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | MEK inhibitor M... leucovorin calc... fluorouracil oxaliplatin pharmacological... Laboratory Biom... | 18 Years - | City of Hope Medical Center | |
| Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | NCT00075595 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer | NCT00081237 | Colorectal Canc... | OSI-7904L oxaliplatin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | NCT00438737 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | NCT00296062 | Colorectal Canc... Unspecified Adu... | bevacizumab capecitabine irinotecan hydr... oxaliplatin | 18 Years - | Case Comprehensive Cancer Center | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00003001 | Colorectal Canc... | fluorouracil gemcitabine hyd... leucovorin calc... | - | National Cancer Institute (NCI) | |
| Genetic Study of Patients and Families With a History of Colorectal Cancer | NCT00003648 | Colorectal Canc... | DNA stability a... gene rearrangem... | - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT00628810 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | NCT00003427 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | irinotecan hydr... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer | NCT00311610 | Colorectal Canc... | SN-38 liposome | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | NCT01814501 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | panitumumab irinotecan hydr... fluorouracil leucovorin calc... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer | NCT00024401 | Colorectal Canc... | DHA-paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | NCT00002796 | Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | fluorouracil sodium phenylbu... indomethacin recombinant int... | - | National Cancer Institute (NCI) | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | NCT00005860 | Cancer | floxuridine leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery | NCT00985400 | Colorectal Canc... | Exercise Progra... Telephone-based... Counseling inte... Questionnaire a... Relaxation Prog... | 18 Years - | M.D. Anderson Cancer Center | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer | NCT00003439 | Cancer | recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT00628810 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | NCT00003674 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Veno-occlusive ... | dalteparin standard therap... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | NCT00033306 | Colorectal Canc... | ixabepilone Fluoropyrimidin... Irinotecan | 18 Years - | University of Alabama at Birmingham | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer | NCT00003344 | Colorectal Canc... | irinotecan hydr... radiation thera... | 18 Years - 120 Years | Medical University of South Carolina | |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | NCT03602079 | HER2-positive B... HER2 Gene Mutat... HER-2 Gene Ampl... HER2 Positive G... Salivary Gland ... Salivary Gland ... Salivary Gland ... Salivary Gland ... Lung Cancer Colo-rectal Can... Rare Diseases Solid Tumor Recurrent Gastr... Recurrent Colon... Recurrent Breas... Head and Neck C... Head and Neck C... Bladder Cancer Cervical Cancer Liver Cancer Bile Duct Cance... Urologic Cancer Pancreatic Canc... Prostate Cancer Recurrent Prost... Rectal Cancer Recurrent Ovari... Recurrent Renal... Rectal Cancer S... Rectal Cancer S... Rectal Cancer S... Skin Cancer Mouth Cancer Lip Cancer Stag... Tongue Cancer Breast Neoplasm... Larynx Cancer Tonsil Cancer Palate Cancer Mucoepidermoid ... Primary Periton... Mucinous Adenoc... Mucinous Breast... Cholangiocarcin... | A166 | 18 Years - | Klus Pharma Inc. | |
| Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | NCT00100841 | Adenocarcinoma ... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | cetuximab bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
